Netlist (NLST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Jul, 2026Executive summary
The 2026 Annual Meeting is scheduled for September 18, 2026, at UCI Research Park, Irvine, CA, with voting on director elections and auditor ratification.
Proxy materials are distributed via both Internet and mail, with voting available online, by phone, mail, or in person.
Only stockholders of record as of July 22, 2026, are eligible to vote.
Voting matters and shareholder proposals
Three directors are nominated for election to serve until the 2027 Annual Meeting.
Ratification of Macias Gini & O'Connell LLP as independent registered public accounting firm for fiscal year 2026 is proposed.
Board recommends voting “FOR” all director nominees and auditor ratification.
Shareholder proposals for the 2027 meeting must be submitted by April 7, 2027.
Board of directors and corporate governance
Board consists of three members, with two deemed independent under Nasdaq standards.
Audit Committee was reinstated in June 2025, with Jun Cho as its sole member and financial expert.
No nominating or compensation committees; the full Board handles these functions.
Board reviews director independence, oversees risk, and manages executive succession planning.
Code of Business Conduct and Ethics applies to all directors, officers, and employees.
Latest events from Netlist
- Shareholders will vote on director elections and auditor ratification at the 2026 annual meeting.NLST
Proxy filing31 Jul 2026 - Record revenue, profitability, and patent enforcement mark strong 2026 performance.NLST
Q2 202630 Jul 2026 - Q1 revenue up 262% to $104.9M, with strong AI demand and legal wins driving profitability.NLST
Q1 202618 May 2026 - Q4 revenue soared 121% year-over-year as AI demand and memory shortages drove sharp price gains.NLST
Q4 20253 Mar 2026 - Q3 sales up 5% to $42.2M, net loss narrowed, but litigation and supply risks persist.NLST
Q3 20253 Feb 2026 - Q2 sales up 267% to $36.8M, $750M in legal wins, but losses and collection risks persist.NLST
Q2 20242 Feb 2026 - Q3 sales up 140% to $40.2M, net loss narrows, and major patent awards boost liquidity.NLST
Q3 202418 Jan 2026 - Revenue surged 113% in 2024, but losses and litigation risks remain high.NLST
Q4 202424 Dec 2025 - Up to $31 million in common stock may be sold to Lincoln Park Capital, with broad use of proceeds.NLST
Registration Filing16 Dec 2025